A phase II trial of bevacizumab (NSC#704865) plus gemcitabine in patients with advanced pancreatic cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 24 Jan 2013 Biomarkers information updated
- 16 Sep 2005 New trial record.